Non-Interventional Report on Parameters of Acceptability, Efficacy and Compliance of Fulvestrant in Post-Menopausal Patients With Advanced Breast Cancer HR Positive Who Progresses to One Prior Endocrine Therapy With Antiestrogens.

Trial Profile

Non-Interventional Report on Parameters of Acceptability, Efficacy and Compliance of Fulvestrant in Post-Menopausal Patients With Advanced Breast Cancer HR Positive Who Progresses to One Prior Endocrine Therapy With Antiestrogens.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jan 2011

At a glance

  • Drugs Fulvestrant (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Acronyms FRAME
  • Sponsors AstraZeneca
  • Most Recent Events

    • 04 Jan 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
    • 04 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Dec 2010 Planned End Date changed from 1 Feb 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top